In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether ...

In this video interview, James Cheong, senior vice president of Asia Pacific at Precision for Medicine, details how NMPA reforms, parallel reviews, and expanded reviewer capacity brought China’s ...

The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health ...

Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.

Risk-based quality management (RBQM) aims to detect the right signals early enough to prevent an issue from occurring. To ...

In this video interview, James Cheong, senior vice president of Asia Pacific at Precision for Medicine, explains how FDA ...

In today’s ACT Brief, we examine why outdated views of Asia Pacific trial sites persist, how community access gaps reflect ...

In this video interview, Kent Thoelke, CEO of Paradigm Health, outlines why anti-kickback guidance and modern EHR-integrated ...

Early-phase drug development often stalls when development, manufacturing, and clinical activities operate independently. Learn how an integrated FIH-to-POC model can help address common bottlenecks, ...

In today’s ACT Brief, we examine how capturing friction in real time can reveal site burden, how OpenAI and Mistral compare ...

In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement ...

In this Q&A, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, discusses ...